Effect of Platelet Rich Plasma and Keratinocyte Suspensions on Wound Healing
Phase 1
Completed
- Conditions
- Skin Graft
- Interventions
- Other: Standard dressingsBiological: Autologous Platelet Rich PlasmaBiological: Keratinocyte suspension
- Registration Number
- NCT00856934
- Lead Sponsor
- Centre Hospitalier Universitaire Vaudois
- Brief Summary
This prospective randomized trial evaluated the impact of autologous keratinocytes suspended in platelet concentrates on healing skin graft donor site wounds. It was hypothesized that the treatment would speed and improve wound healing.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
- Skin graft donor sites total surface < 15% BSA
- Skin graft donor site size: 0.2mm deep, 30 to 40 cm2 surface area
Exclusion Criteria
- Patients treated with immunosuppressors
- Patients treated with corticoids
- Patients suffering from terminal renal insufficiency
- Patients suffering from severe peripheral arteriopathy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Standard dressings Wounds covered with standard dressings: three layers of paraffin gauze, standard bandages, elastic bandage. PRP Autologous Platelet Rich Plasma PRP sprayed onto the wound bed with Calcium Choride. Wounds covered with same standard dressings used in control group. PRP Standard dressings PRP sprayed onto the wound bed with Calcium Choride. Wounds covered with same standard dressings used in control group. PRP+K Autologous Platelet Rich Plasma Keratinocytes suspended in PRP sprayed onto the wound bed with Calcium Choride. Wounds covered with same standard dressings used in control group. PRP+K Keratinocyte suspension Keratinocytes suspended in PRP sprayed onto the wound bed with Calcium Choride. Wounds covered with same standard dressings used in control group. PRP+K Standard dressings Keratinocytes suspended in PRP sprayed onto the wound bed with Calcium Choride. Wounds covered with same standard dressings used in control group.
- Primary Outcome Measures
Name Time Method Complete Wound Healing Post operative day 5 and every other day thereafter Time required for complete epithelialization in days
- Secondary Outcome Measures
Name Time Method Pain Post operative day 5 Pain evaluated on a Visual Analog Scale (VAS) from 0 (no pain) to 10 (extreme pain), specifically during dressing replacement.
Trial Locations
- Locations (1)
Centre hospitalier Universitaire Vaudois
🇨🇭Lausanne, Vaud, Switzerland